REGN vs UIS · P/E 14, rev $14.34B vs rev $1.95B
Regeneron Pharmaceuticals Inc (REGN) versus Unisys Corporation (UIS) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Unisys Corporation (UIS) is a information technology services company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UIS revenue for 2025-12-31 was $1.95B. Net income was -$339.8M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. UIS currently screens at market cap $266.1M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UIS currently screens at market cap $266.1M.
Not investment advice. Open the REGN and UIS stock pages for the full models.
Not investment advice.